Pretreatment with KGA-2727, a selective SGLT1 inhibitor, is protective against myocardial infarction-induced ventricular remodeling and heart failure in mice

• Asıl Yazarlar: Yohei Sawa (Yazar), Maki Saito (Yazar), Nanae Ishida (Yazar), Miho Ibi (Yazar), Naoko Matsushita (Yazar), Yoshihiro Morino (Yazar), Eiichi Taira (Yazar), Masamichi Hirose (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2020-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Recent studies demonstrated that sodium-glucose co-transporter 1 (SGLT1) is associated with human ischemic cardiomyopathy. However, whether SGLT1 blockade is effective against ischemic cardiomyopathy is still uncertain. We examined the effects of KGA-2727, a selective SGLT1 inhibitor, on myocardial...